Norbert Schmitz is involved in biostatistics, psychiatric epidemiology and psychometrics.  

Bruno Giros characterizes the neurobiology of schizophrenia and develops improved genetic animal models of this illness.

As a clinician, Johanne Renaud holds the title of medical chief for the youth section of the Douglas Institute’s Depressive Disorders Program.

Aurélie Labbe is a biostatistician who specializes in statistical genetics and genetic epidemiology.

Suzanne King is investigating  risk factors for schizophrenia, such as prenatal stress, obstetric complications, and cannabis use.

Natalie Grizenko is medical director with the mandate of integrating research, teaching and clinical excellence throughout the program.

Gustavo Turecki investigates the neurobiology of suicide, focusing on the role of genetic risk factors.

Howard Steiger contributed to the advancement of knowledge regarding causal mechanisms and clinical management of eating disorders.

Pedro Rosa-Neto is interested in the structural changes that occur in the brain as a result of neurodegenerative disease.

Michel Perreault's main focus is the evaluation of psychiatric and substance abuse programs.